Prostate Cancer - Results from #920

Comparison of quantitative whole body PET parameters on [68Ga]Ga-PSMA-11 PET/CT using ordered Subset Expectation Maximization (OSEM) vs. bayesian penalized likelihood (BPL) reconstruction algorithms in men with metastatic castration-resistant prostate can May 8, 2024

Clinically Significant Prostate Cancer Detection Following Transrectal and Transperineal Biopsy: Results of the Prostate Biopsy Efficacy and Complications Randomized Clinical Trial. May 8, 2024

Prostate-specific Membrane Antigen: Diagnostics. May 8, 2024

Prostate cancer diagnosis rates among insured men with and without HIV in South Africa: a cohort study. May 8, 2024

Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI. May 8, 2024

Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer. May 8, 2024

Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial May 7, 2024

The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy. May 7, 2024

A Comprehensive Review of the Current State of Robot-assisted Laparoscopic Salvage Prostatectomy. May 7, 2024

Prostate-specific Membrane Antigen: Interpretation Criteria, Standardized Reporting, and the Use of Machine Learning. May 7, 2024

Deep learning based automatic segmentation of the Internal Pudendal Artery in definitive radiotherapy treatment planning of localized prostate cancer. May 7, 2024

Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study. May 7, 2024

Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial. May 6, 2024

Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going. May 6, 2024

PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI. May 6, 2024

Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis. May 6, 2024

The rates of septicemia in older adults with prostate cancer treated with abiraterone or enzalutamide: A population-based study. May 6, 2024

Androgen Deprivation Therapy/Androgen Receptor Signaling Inhibitor Treatments for Prostate Cancer: Pathophysiology and Review of Effects on Cardiovascular Disease. May 6, 2024

Safety and Efficacy of Extended Therapy with [177Lu]Lu-PSMA: A German Multicenter Study. May 6, 2024

Plant-Based Diets and Disease Progression in Men With Prostate Cancer. May 3, 2024

Page 47 of 1435